does eli lilly make tirzepatide F.D.A. Approves New Obesity Drug That Will Compete With Wegovy FDA approves tirzepatide, Eli Lilly's

fact sheet (2021)

Zepbound should not be used with other tirzepatide-containing products or any GLP-1 receptor agonist medicines, and it has not been studied in patients with a history of pancreatitis, or with severe gastrointestinal disease, including severe gastroparesis

When insurance formularies shift, patients who were stable on tirzepatide suddenly find themselves facing out-of-pocket costs exceeding $1,000 per month

You can learn more about the medicines you may be prescribed on our medications page

The search for safe and effective pharmacologic weight-loss agents began in the late 19th century with the discovery that sheep thyroid extract increased metabolic rate and induced significant weight loss